XTX Topco’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.05M | Buy |
6,066
+2,320
| +62% | +$400K | 0.04% | 639 |
|
2025
Q1 | $584K | Buy |
+3,746
| New | +$584K | 0.03% | 914 |
|
2024
Q4 | – | Sell |
-11,333
| Closed | -$1.69M | – | 2267 |
|
2024
Q3 | $1.69M | Buy |
+11,333
| New | +$1.69M | 0.12% | 194 |
|
2023
Q4 | – | Sell |
-2,398
| Closed | -$225K | – | 1575 |
|
2023
Q3 | $225K | Sell |
2,398
-243
| -9% | -$22.8K | 0.04% | 953 |
|
2023
Q2 | $236K | Buy |
+2,641
| New | +$236K | 0.04% | 895 |
|
2021
Q4 | – | Sell |
-3,250
| Closed | -$518K | – | 676 |
|
2021
Q3 | $518K | Buy |
+3,250
| New | +$518K | 0.17% | 179 |
|